Through scRNA-seq analysis, we identified CD8+GZMK+CCR7+ Tsa cells as key immunopathological effectors whose circulating levels correlated significantly with neurological deficit scores and predicted long-term functional outcomes in AIS patients. The gene discussed is PRDX2; the disease is androgen insensitivity syndrome.